Tom Pike

Former Chief Risk Officer at Accenture PLC

Tom Pike

Tom Pike

Former Chief Risk Officer at Accenture PLC

Overview
Career Highlights

Quintiles Transnational Holdings, Inc.
Quintiles Transnational Corp.
Accelion, Inc.

RelSci Relationships

1681

Number of Boards

6

Birthday

1960

Age

58

Relationships
RelSci Relationships are individuals Tom Pike likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at GHO Capital Partners LLP

Relationship likelihood: Strong

Chairman & Chief Executive Officer at IQVIA Holdings, Inc.

Relationship likelihood: Strong

Founding Partner at TPG Growth LLC

Relationship likelihood: Strong

Chief Executive Officer, Covance Drug Development at Laboratory Corporation of America Holdings

Relationship likelihood: Strong

Director at Hasbro International, Inc.

Relationship likelihood: Strong

Partner at TPG Capital LLC

Relationship likelihood: Strong

Managing Director at Bain Capital Private Equity LP

Relationship likelihood: Strong

Co-Managing Partner at Bain Capital Private Equity LP

Relationship likelihood: Strong

Professional at PARx Solutions, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Intellia Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Tom Pike
Potential Connections via
Relationship Science
You
Tom Pike
Former Chief Risk Officer at Accenture PLC
Education
Bachelor of Science in Accounting

The University of Delaware (UD) is a state-assisted, privately governed institution that was founded in 1743. It offers 3 associate programs, 147 bachelor’s programs, 119 master's programs, 54 doctoral programs, and 15 dual graduate programs through seven colleges and in collaboration with more than 70 research centers. UD's student body encompasses more than 17,000 undergraduates, more than 3,600 graduate students and nearly 800 students in professional and continuing studies from across the country and around the globe. The University received its charter from the State of Delaware in 1833 and was designated one of the nation’s historic Land Grant colleges in 1867. Today, UD is a Land Grant, Sea Grant and Space Grant institution. The Carnegie Foundation for the Advancement of Teaching classifies UD as a research university with very high research activity—a designation accorded less than 3 percent of U.S. colleges and universities. UD ranks among the nation’s top 100 universities in federal R&D support for science and engineering.

Career History
Chief Executive Officer
2012 - 2016

Quintiles is the largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize all of the top 50 best selling drugs on the market. With extensive therapeutic, scientific and analytics expertise, we help biopharmaceutical and health sciences customers navigate the increasingly complex landscape with more predictability to enable better outcomes.

Chief Executive Officer & Director
2012 - Prior

Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC.

Vice Chairman
2012 - 2016

IQVIA Holdings, Inc. is a biotechnology company, which engages in healthcare development in the provision of professional services, information technology, and partnering solutions to the pharmaceutical services and healthcare industries. The company was founded by Dennis Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Boards & Committees
Chief Executive Officer & Director
2012 - Prior

Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC.

Member, Board of Directors
2012 - 2016

IQVIA Holdings, Inc. is a biotechnology company, which engages in healthcare development in the provision of professional services, information technology, and partnering solutions to the pharmaceutical services and healthcare industries. The company was founded by Dennis Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Member, Board of Directors
2012 - 2016

Quintiles is the largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize all of the top 50 best selling drugs on the market. With extensive therapeutic, scientific and analytics expertise, we help biopharmaceutical and health sciences customers navigate the increasingly complex landscape with more predictability to enable better outcomes.

Political Donations
$5,000
2008
$1,500
2007
$1,000
2006
Transactions
Details Hidden

Quintiles Transnational Holdings, Inc. issued Common Stock

Details Hidden

Quintiles Transnational Holdings, Inc. issued Common Stock

Public Holdings
Restricted data only for RelSci Professional users.